Case Report: Pseudohepatotoxicity of metformin

Swislocki, Arthur L M; Noth, Robert

doi:10.2337/diacare.21.4.677b

Article navigation

Letters| April 01 1998

Case Report: Pseudohepatotoxicity of metformin

Arthur L M Swislocki, MD, FACP;

Arthur L M Swislocki, MD, FACP fn1

Medical Service, Department of Veterans Affairs Northern California Health Care System

Martinez

Department of Internal Medicine, Division of Endocrinology, University of California, Davis, School of Medicine

Davis, California

Search for other works by this author on:

This Site

PubMed

Google Scholar

Robert Noth, MD

Medical Service, Department of Veterans Affairs Northern California Health Care System

Martinez

Department of Internal Medicine, Division of Endocrinology, University of California, Davis, School of Medicine

Davis, California

Search for other works by this author on:

This Site

PubMed

Google Scholar

1

A.L.M.S. has received honoraria for speaking engagements from Bristol-Myers Squibb, Pfizer, and Merck and unrestricted research support from Bristol-Myers Squibb.

Address correspondence to Arthur Swislocki, MD, FACR Medical Service (111), VANCHCS, 150 Muir Road, Martinez, CA 94553.

Diabetes Care 1998;21(4):677–678

https://doi.org/10.2337/diacare.21.4.677b

Case Report: Pseudohepatotoxicity of metformin

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Case Report: Pseudohepatotoxicity of metformin

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only